Biostax Corp. and Statera Biopharma, Inc. reach mutually beneficial dispute settlement and amended license agreement providing clearer clinical and commercial pathways for both companies20230420133702
Biostax Corp. and Statera Biopharma, Inc. reach mutually beneficial dispute settlement and amended license agreement providing clearer clinical and commercial pathways for both companies
The settlement between Statera Biopharma, Inc. and Biostax Corp. includes an amended royalty-bearing license agreement and a joint petition to dismiss...
2023 BioFlorida Conference | Ponte Vedra Beach20230301205713
2023 BioFlorida Conference | Ponte Vedra Beach
Biostax Corp. Will Be Attending! As the conference date nears, we will provide information on meeting schedules.DATE: Wed. October 11 - Fri. October ...
Immune Therapeutics, Inc. Announces Shareholder Approval of Name Change to Biostax Corp. and Unveils New Website, Business Strategies and Direction20230301143634
Immune Therapeutics, Inc. Announces Shareholder Approval of Name Change to Biostax Corp. and Unveils New Website, Business Strategies and Direction
Immune Therapeutics, Inc. Announces Shareholder Approval of Name Change to Biostax Corp. and Unveils New Website, Business Strategies and Direction. O...
March 13-14 2023 BIOFLORIDA EVENT: BioFlorida Day at the Capitol (members-only) | Tallahassee20230125125905
March 13-14 2023 BIOFLORIDA EVENT: BioFlorida Day at the Capitol (members-only) | Tallahassee
INTERESTED IN GETTING YOUR COMPANY INVOLVED? BioFlorida is pleased to offer sponsorships and exhibit opportunities to showcase your organization in th...